Cowen Reiterates “Buy” Rating for MKS Instruments (MKSI)

MKS Instruments (NASDAQ:MKSI)‘s stock had its “buy” rating restated by equities researchers at Cowen in a note issued to investors on Monday, February 4th.

Several other equities analysts have also issued reports on MKSI. Zacks Investment Research lowered shares of MKS Instruments from a “hold” rating to a “sell” rating in a report on Tuesday, January 29th. KeyCorp cut their price objective on shares of MKS Instruments from $135.00 to $112.00 and set an “overweight” rating on the stock in a report on Thursday, October 25th. BidaskClub raised shares of MKS Instruments from a “sell” rating to a “hold” rating in a report on Thursday, October 18th. Finally, ValuEngine lowered shares of MKS Instruments from a “sell” rating to a “strong sell” rating in a report on Tuesday, December 25th. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the company’s stock. MKS Instruments currently has a consensus rating of “Hold” and an average price target of $117.71.

Shares of MKS Instruments stock traded up $0.98 on Monday, hitting $83.85. 273,118 shares of the company traded hands, compared to its average volume of 560,618. The company has a debt-to-equity ratio of 0.18, a quick ratio of 4.10 and a current ratio of 5.56. MKS Instruments has a 52 week low of $56.37 and a 52 week high of $128.28. The company has a market capitalization of $4.56 billion, a PE ratio of 10.71, a P/E/G ratio of 1.07 and a beta of 1.31.

MKS Instruments (NASDAQ:MKSI) last posted its quarterly earnings results on Tuesday, January 29th. The scientific and technical instruments company reported $1.54 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.51 by $0.03. MKS Instruments had a net margin of 18.93% and a return on equity of 23.96%. The firm had revenue of $460.54 million during the quarter, compared to the consensus estimate of $440.68 million. During the same quarter in the previous year, the firm posted $1.71 earnings per share. On average, analysts forecast that MKS Instruments will post 6.59 earnings per share for the current year.

In other MKS Instruments news, Director Elizabeth Mora sold 375 shares of MKS Instruments stock in a transaction on Monday, December 3rd. The shares were sold at an average price of $79.90, for a total value of $29,962.50. Following the transaction, the director now directly owns 15,412 shares of the company’s stock, valued at $1,231,418.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.67% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MKSI. Legal & General Group Plc lifted its stake in shares of MKS Instruments by 0.3% during the third quarter. Legal & General Group Plc now owns 63,491 shares of the scientific and technical instruments company’s stock worth $5,089,000 after buying an additional 166 shares during the period. Benjamin F. Edwards & Company Inc. lifted its stake in shares of MKS Instruments by 53.0% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 514 shares of the scientific and technical instruments company’s stock worth $33,000 after buying an additional 178 shares during the period. Oregon Public Employees Retirement Fund lifted its stake in shares of MKS Instruments by 1.1% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 21,944 shares of the scientific and technical instruments company’s stock worth $1,418,000 after buying an additional 230 shares during the period. Penserra Capital Management LLC lifted its stake in shares of MKS Instruments by 89.8% during the fourth quarter. Penserra Capital Management LLC now owns 672 shares of the scientific and technical instruments company’s stock worth $43,000 after buying an additional 318 shares during the period. Finally, James Investment Research Inc. lifted its stake in shares of MKS Instruments by 13.5% during the fourth quarter. James Investment Research Inc. now owns 2,966 shares of the scientific and technical instruments company’s stock worth $192,000 after buying an additional 353 shares during the period. 91.20% of the stock is currently owned by institutional investors and hedge funds.

MKS Instruments Company Profile

MKS Instruments, Inc provides instruments, subsystems, and process control solutions that measure, control, power, deliver, monitor, and analyze critical parameters of manufacturing processes worldwide. The company operates through two segments, Vacuum & Analysis and Light & Motion. The Vacuum & Analysis segment provides analytical and control solutions products, including gas analyzers, automation control products, I/O modules, automation software, and precision machined components and electromechanical assemblies; and materials delivery solutions products comprising flow and valve technologies, as well as integrated pressure measurement and control subsystems to provide customers with precise control capabilities that are optimized for a given application.

Featured Article: What is Cost of Debt?

Analyst Recommendations for MKS Instruments (NASDAQ:MKSI)

Receive News & Ratings for MKS Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply